Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment-Reference-Cited by-同舟云学术

Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment

Published:2017-01-11 Issue:4 Volume:6 Page:377-387
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Shen Zancong¹,Tieu Kathy¹,Wilson David¹,Bucci Gail¹,Gillen Michael²,Lee Caroline¹,Kerr Bradley¹

Affiliation:

1. Ardea Biosciences; Inc; San Diego CA USA

2. AstraZeneca LP; Gaithersburg MD USA

Funder

PAREXEL

AstraZeneca

Ardea Biosciences, Inc., a member of the AstraZeneca group

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference39 articles.

1. Definition of hyperuricemia and gouty conditions;Bardin;Curr Opin Rheumatol,2014

2. Treating to target: a strategy to cure gout;Perez-Ruiz;Rheumatology (Oxford),2009

3. Quality of life and disability in patients with treatment-failure gout;Becker;J Rheumatol,2009

4. Chronic gout: epidemiology, disease progression, treatment and disease burden;Brook;Curr Med Res Opin,2010

5. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout;Jordan;Rheumatology (Oxford),2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N,N-Disubstituted 4-Sulfamoylbenzoic Acid Derivatives as Inhibitors of Cytosolic Phospholipase A_2α: Synthesis, Aqueous Solubility, and Activity in a Vesicle and a Whole Blood Assay;Medicinal Chemistry;2024-12

2. Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro;Toxicology in Vitro;2024-06

3. Urate‐Lowering Drugs and Muscle Injury: A Systematic Review and Network Meta‐Analysis;The Journal of Clinical Pharmacology;2023-10-30

4. Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management;Drug Safety;2022-12-15

5. A novel quality by design approach for development and validation of a green reversed‐phase HPLC method with fluorescence detection for the simultaneous determination of lesinurad, febuxostat, and diflunisal: Application to human plasma;Journal of Separation Science;2021-04-15